| Product sales | 3.33M |
| Research and development under cooperative agreement | |
| Total revenues | 3.33M |
| Cost of product sales | 2.94M |
| Cost of research and development under cooperative agreement | 0 |
| Gross Margin | 385.83K |
| Selling, general and administrative expense | 763.26K |
| Operating income | -377.43K |
| Other income (expense), net | |
| Net income before income tax expense | |
| Income tax expense | |
| Net income | |
| Net income per basic common share | -0.01 |
| Weighted average number of basic common shares outstanding | 13.2M |
| Net income (loss) per diluted common share | -0.01 |
| Weighted average number of diluted common shares outstanding | 13.2M |